Dr Russell Hal Gerry, MD | |
1515 Medical Center Dr, Wilmington, NC 28401-7507 | |
(910) 796-9969 | |
(910) 796-0270 |
Full Name | Dr Russell Hal Gerry |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 39 Years |
Location | 1515 Medical Center Dr, Wilmington, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811992340 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 9901182 (North Carolina) | Primary |
Entity Name | Center For Integrated Health Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306946090 PECOS PAC ID: 7719904002 Enrollment ID: O20071120000069 |
News Archive
FotoFinder presents advanced devices for early skin cancer detection at the World Congress of Dermoscopy in Brisbane from May 17 to 19. The new mobile and stationary devices offer better diagnostic accuracy for doctors and more safety for patients. Latest development is the connection of a mobile dermatoscope for iPhone with an online webspace where doctors can request a second opinion on suspicious moles.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Human dihydroorotate dehydrogenase (DHODH) is a viable target for the development of therapeutics to treat cancer and immunological diseases, such as rheumatoid arthritis (RA), psoriasis and multiple sclerosis (MS).
The Catholic bishops said that, without quick congressional action, their organization will sue the Obama administration for requiring insurance plans to provide birth control to women without a co-pay.
Hospitals will quickly slash the rate of common, costly and potentially lethal catheter-related bloodstream infections in their intensive care units (ICUs) by using cheap, low-tech, common-sense measures like hand washing, timely removal of unneeded catheters, and use of sites other than the groin to place lines when possible, according to a report from safety experts at Johns Hopkins in the New England Journal of Medicine.
› Verified 6 days ago
Entity Name | Carter Clinic, P A |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912959834 PECOS PAC ID: 1254429921 Enrollment ID: O20091216000437 |
News Archive
FotoFinder presents advanced devices for early skin cancer detection at the World Congress of Dermoscopy in Brisbane from May 17 to 19. The new mobile and stationary devices offer better diagnostic accuracy for doctors and more safety for patients. Latest development is the connection of a mobile dermatoscope for iPhone with an online webspace where doctors can request a second opinion on suspicious moles.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Human dihydroorotate dehydrogenase (DHODH) is a viable target for the development of therapeutics to treat cancer and immunological diseases, such as rheumatoid arthritis (RA), psoriasis and multiple sclerosis (MS).
The Catholic bishops said that, without quick congressional action, their organization will sue the Obama administration for requiring insurance plans to provide birth control to women without a co-pay.
Hospitals will quickly slash the rate of common, costly and potentially lethal catheter-related bloodstream infections in their intensive care units (ICUs) by using cheap, low-tech, common-sense measures like hand washing, timely removal of unneeded catheters, and use of sites other than the groin to place lines when possible, according to a report from safety experts at Johns Hopkins in the New England Journal of Medicine.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Russell Hal Gerry, MD 1515 Medical Center Dr, Wilmington, NC 28401-7507 Ph: (910) 796-9969 | Dr Russell Hal Gerry, MD 1515 Medical Center Dr, Wilmington, NC 28401-7507 Ph: (910) 796-9969 |
News Archive
FotoFinder presents advanced devices for early skin cancer detection at the World Congress of Dermoscopy in Brisbane from May 17 to 19. The new mobile and stationary devices offer better diagnostic accuracy for doctors and more safety for patients. Latest development is the connection of a mobile dermatoscope for iPhone with an online webspace where doctors can request a second opinion on suspicious moles.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) and granted a six-month Priority Review for once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection among uninfected adults.
Human dihydroorotate dehydrogenase (DHODH) is a viable target for the development of therapeutics to treat cancer and immunological diseases, such as rheumatoid arthritis (RA), psoriasis and multiple sclerosis (MS).
The Catholic bishops said that, without quick congressional action, their organization will sue the Obama administration for requiring insurance plans to provide birth control to women without a co-pay.
Hospitals will quickly slash the rate of common, costly and potentially lethal catheter-related bloodstream infections in their intensive care units (ICUs) by using cheap, low-tech, common-sense measures like hand washing, timely removal of unneeded catheters, and use of sites other than the groin to place lines when possible, according to a report from safety experts at Johns Hopkins in the New England Journal of Medicine.
› Verified 6 days ago
Dr. James Carden Mccabe, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1302 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-9800 Fax: 910-343-9800 | |
Michael Mundy Ward, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2215 Canterwood Dr, Wilmington, NC 28401 Phone: 910-762-4600 Fax: 910-762-9483 | |
Latessa Spiers, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1960 S 16th St, Wilmington, NC 28401 Phone: 910-343-9991 | |
Dr. Kavita S Persaud, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5919 Oleander Dr Ste 109, Wilmington, NC 28403 Phone: 910-799-5508 Fax: 910-202-0654 | |
Dr. Regina Marie Jensen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4536 Technology Dr, Ste 3, Wilmington, NC 28405 Phone: 910-343-8411 Fax: 910-343-8414 | |
Mary Kathryn Rudyk, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1709 S 16th St Ste A, Wilmington, NC 28401 Phone: 910-452-8633 Fax: 910-452-8569 | |
Gregory Roberts, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-341-7946 |